Literature DB >> 16473324

Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranes.

Peter L Hargreaves1, Thanh-Son Nguyen, Robert O Ryan.   

Abstract

Nanodisks (ND) are discrete nanometer scale phospholipid bilayers whose perimeter is circumscribed by amphipathic apolipoproteins. The membranous environment of ND serves as a matrix for solubilizing the polyene antibiotic amphotericin B (AMB). The spectral properties of AMB in ND are dependent upon AMB concentration. Whereas AMB-ND prepared at a concentration of 2.5 mg AMB per 10 mg phospholipid are consistent with AMB self association in the ND membrane environment, AMB-ND prepared at 0.25 or 0.025 mg AMB per 10 mg phospholipid give rise to spectra reminiscent of AMB in organic solvent. Incubation of ND prepared at a phospholipid/AMB ratio of 400:1 (w/w) at 37 degrees C for 1 h induced a shift in absorbance and near UV circular dichroism spectra consistent with antibiotic self-association. The kinetics of this spectral transition were investigated as a function of incubation temperature. While no change in A388 nm occurred in incubations at 20 degrees C, a time-dependent decrease in A388 nm was observed at 25, 30 and 37 degrees C. Inclusion of ergosterol in the ND membrane attenuated temperature-induced AMB spectral changes. In Saccharomyces cerevisiae growth inhibition assays, ND containing self associated AMB were somewhat less effective than ND possessing a greater proportion of monomeric AMB. On the other hand, inclusion of ergosterol or cholesterol in the ND particle did not alter the growth inhibition properties of AMB-ND. The miniature membrane environment of ND provides a novel milieu for solubilization and characterization of lipophilic biomolecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473324     DOI: 10.1016/j.bbamem.2006.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Reconstituted HDL as a therapeutic delivery device.

Authors:  Colin A Fox; Anthony Moschetti; Robert O Ryan
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-08-08       Impact factor: 5.228

2.  Polyenes in Medium Chain Length Polyhydroxyalkanoate (mcl-PHA) Biopolymer Microspheres with Reduced Toxicity and Improved Therapeutic Effect against Candida Infection in Zebrafish Model.

Authors:  Aleksandar Pavic; Zoran Stojanovic; Marina Pekmezovic; Đorđe Veljović; Kevin O'Connor; Ivana Malagurski; Jasmina Nikodinovic-Runic
Journal:  Pharmaceutics       Date:  2022-03-24       Impact factor: 6.525

3.  Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers.

Authors:  Thanh-Son Nguyen; Paul M M Weers; Vincent Raussens; Zhen Wang; Gang Ren; Todd Sulchek; Paul D Hoeprich; Robert O Ryan
Journal:  Biochim Biophys Acta       Date:  2007-10-16

4.  Nanodisks derived from amphotericin B lipid complex.

Authors:  Megan Tufteland; Gang Ren; Robert O Ryan
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

5.  All-trans-retinoic acid nanodisks.

Authors:  Katherine A Redmond; Thanh-Son Nguyen; Robert O Ryan
Journal:  Int J Pharm       Date:  2007-03-06       Impact factor: 5.875

6.  Imaging of human cells exposed to an antifungal antibiotic amphotericin B reveals the mechanisms associated with the drug toxicity and cell defence.

Authors:  Ewa Grela; Mateusz Piet; Rafal Luchowski; Wojciech Grudzinski; Roman Paduch; Wieslaw I Gruszecki
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

7.  Modes of the antibiotic activity of amphotericin B against Candida albicans.

Authors:  Ewa Grela; Agnieszka Zdybicka-Barabas; Bozena Pawlikowska-Pawlega; Malgorzata Cytrynska; Monika Wlodarczyk; Wojciech Grudzinski; Rafal Luchowski; Wieslaw I Gruszecki
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 8.  Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.

Authors:  Daniel Michał Kamiński
Journal:  Eur Biophys J       Date:  2014-08-31       Impact factor: 1.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.